Previous close | 1.2000 |
Open | N/A |
Bid | 0.5500 |
Ask | 3.1000 |
Strike | 40.00 |
Expiry date | 2024-05-17 |
Day's range | 1.2000 - 1.2000 |
Contract range | N/A |
Volume | |
Open interest | 1 |
IRADIMED ( NASDAQ:IRMD ) First Quarter 2024 Results Key Financial Results Revenue: US$17.6m (up 14% from 1Q 2023). Net...
Continued Growth in MRI-Compatible Devices and Strong Financial Outlook
Reports record revenue of $17.6 million for the first quarter of 2024.Reports GAAP diluted EPS of $0.32 and non-GAAP diluted EPS of $0.36 for the first quarter of 2024.Reports first quarter of 2024 operating income of $4.7 million, an increase of 18.5 percent compared to the same period in 2023.Declares a regular quarterly cash dividend of $0.15 per common share for the second quarter of 2024, payable May 30, 2024. WINTER SPRINGS, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the